OxTalks will soon be transitioning to Oxford Events (full details are available on the Staff Gateway). A two-week publishing freeze is expected in early Hilary to allow all events to be migrated to the new platform. During this period, you will not be able to submit or edit events on OxTalks. The exact freeze dates will be confirmed as soon as possible.
If you have any questions, please contact halo@digital.ox.ac.uk
Rheumatoid Arthritis (RA) is a complex and heterogeneous inflammatory disorder, where many patients (but not all) display clear autoimmune features characterized by MHC class II association and autoantibody production. Disease develops gradually during a long time period with different compartments being the site of initiation (lung) versus disease precipitation (joints). A functional understanding of this stepwise process is emerging.
We study B and T cells and their effector functions in blood, joints and lungs of RA patients. We utilize peptide – HLA-DR-tetramers as well as antigen-tetramers (for specific T and B cell capture respectively).
Expression of recombinant IgG (BCR) from RA-derived B cells has e.g. revealed an inflammation-independent, but autoimmune, mechanism for pain and bone erosion, explaining some of the conundrums of early aggressive disease.
The possibility to capture antigen-specific lymphocytes is currently applied for immunosurveillance of the autoimmune lymphocyte repertoire in RA patients over time and in response to therapeutic intervention.
